All In Biotech

Free tool

FAERS Monitor: Aczone

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207154 or its brand name (Aczone, Dapsone). Reports on generic versions are filed under their own applications.

Reports

10,863

Serious

8,218

76% of reports

Hospitalization

3,865

Death reported

935

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,306
  • drug ineffective1,166
  • methaemoglobinaemia498
  • nausea492
  • fatigue487
  • pyrexia474
  • diarrhoea426
  • rash405
  • drug reaction with eosinophilia and systemic symptoms399
  • dyspnoea392
  • pneumonia385
  • pain376
  • anaemia374
  • condition aggravated366
  • treatment failure364

Reports by year received

View as table
YearReports
2004143
2005145
2006165
2007104
2008193
2009232
2010212
2011232
2012274
2013173
2014311
2015441
2016566
2017647
2018732
2019733
2020927
2021709
2022807
2023687
2024872
2025890
2026665

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,296 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
methaemoglobinaemiaSignal498530.3481.2206,172
drug reaction with eosinophilia and systemic symptomsSignal39930.527.711,185
treatment failureSignal3648.57.72,415
anaemiaSignal3743.83.4775
off label useSignal1,3062.92.71,681
pyrexiaSignal4742.72.4495
condition aggravatedSignal3662.32.1281
pneumoniaSignal3852.32.1287
rash4051.81.6146
drug ineffective1,1661.71.6369
dyspnoea3921.31.235
diarrhoea4261.31.226
fatigue4871.21.118
nausea4921.21.117
pain3761.21.111

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.